WebAug 8, 2013 · Dutch Colorectal Cancer Group: ClinicalTrials.gov Identifier: NCT01918852 Other Study ID Numbers: SALTO : First Posted: August 8, 2013 Key Record Dates: Last … WebWelcome to the website of the Cochrane Colorectal Group. We are an entity of Cochrane, an international non-profit and independent organisation, dedicated to keeping information about the effects of healthcare accurate, up to date and available to healthcare providers and the public. The Cochrane Colorectal Group is one of 52 collaborative ...
Treatment Holidays for Patients With Metastatic Colorectal Cancer …
WebThe Dutch Cancer Society, the Dutch National Health Council, and the Swedish Cancer Society. Preoperative radiotherapy combined with total mesorectal excision for … WebApr 6, 2024 · The Intervention Selection Toolbox was used by the colorectal cancer multidisciplinary quality improvement team for decision making in colorectal cancer care in a large non-academic teaching hospital, which is part of the Santeon consortium. Santeon is a Dutch consortium of seven teaching hospitals. gas leak emergency number nsw
Colorectal Cancer Proteintech Group
WebRadioembolization with 166Ho-microspheres in elderly and/or fragile patients with previously untreated unresectable liver-only metastases of colorectal cancer, CAIRO7 study endorsed by the Dutch Colorectal Cancer Group (DCCG) Study CAMINO Clinical added value of MRI over CT in patients scheduled for colorectal liver metastases resection Study WebApr 14, 2024 · Colorectal cancer is a leading cause of morbidity and mortality across U.S. racial/ethnic groups. Existing studies often focus on a particular race/ethnicity or single domain within the care continuum. Granular exploration of disparities among different racial/ethnic groups across the entire colon cancer care continuum is needed. We aimed … WebThis multicenter study was conducted by the Danish and Dutch Colorectal Cancer Group in general and academic hospitals in Denmark and the Netherlands. Patients included between August 2012 and December 2024 with histologically proven colorectal cancer, unresectable metastases, and a primary tumor with few or absent symptoms were eligible. david chorlton